Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient

被引：3
|
作者：
Hannoun, Salem [1 ,2 ,3 ]
Durand-Dubief, Francoise [1 ,2 ,4 ,5 ]
Roch, Jean-Amedee [6 ]
Sappey-Marinier, Dominique [1 ,2 ,7 ]
Cotton, Francois [1 ,2 ,6 ]
机构：
[1] Univ Lyon 1, CREATIS CNRS UMR 5220, F-69100 Villeurbanne, France
[2] Univ Lyon 1, Inserm U1044, F-69100 Villeurbanne, France
[3] Amer Univ Beirut, Fac Med, Abu Haidar Neurosci Inst, Beirut, Lebanon
[4] Hop Neurol & Neurochirurg P Wertheimer, Serv Neurol A, F-69677 Bron, France
[5] Hop Neurol & Neurochirurg P Wertheimer, EDMUS Coordinating Ctr Multiple Sclerosis, F-69677 Bron, France
[6] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Radiol, F-69495 Pierre Benite, France
[7] CERMEP Imagerie Vivant, Dept IRM, F-69677 Bron, France
来源：
JOURNAL OF NEURORADIOLOGY | 2016年 / 43卷 / 05期
关键词：
APPEARING WHITE-MATTER; WATER DIFFUSION; AXONAL DAMAGE; DEMYELINATION; INFLAMMATION; MECHANISMS; PATHOLOGY; LESIONS; NERVE; MS;
D O I：
10.1016/j.neurad.2016.05.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：359 / 361
页数：3
相关论文
共 50 条
  • [1] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [2] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [3] An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
    Saleem, Sidra
    Anwar, Arsalan
    Fayyaz, Muniba
    Anwer, Fatima
    Anwar, Faria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [4] Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis
    Boster, Aaron
    Hreha, Stephanie
    Berger, Joseph R.
    Bao, Fen
    Penmesta, Ramya
    Tselis, Alexandros
    Endress, Christina
    Zak, Imad
    Perumal, Jai
    Caon, Christina
    Vazquez, Jose
    Tyler, Kenneth L.
    Racke, Michael K.
    Millis, Scott
    Khan, Omar
    ARCHIVES OF NEUROLOGY, 2009, 66 (05) : 593 - 599
  • [5] Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis
    Rinaldi, F.
    Calabrese, M.
    Seppi, D.
    Puthenparampil, M.
    Perini, P.
    Gallo, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1760 - 1767
  • [6] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [7] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [8] Current management of relapsing-remitting multiple sclerosis
    Sedal, L.
    Wilson, I. B.
    McDonald, E. A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
  • [9] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence
    Bayas, Antonios
    Maeurer, Mathias
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 265 - 274
  • [10] Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
    Rossi, Silvia
    Studer, Valeria
    Motta, Caterina
    Polidoro, Serena
    Perugini, Jacopo
    Macchiarulo, Giulia
    Giovannetti, Ambra Mara
    Pareja-Gutierrez, Lorena
    Calo, Andrea
    Colonna, Isabella
    Furlan, Roberto
    Martino, Gianvito
    Centonze, Diego
    NEUROLOGY, 2017, 89 (13) : 1338 - 1347
12345